Chemoinformaics analysis of (2S,4S)-PINNATANINE
| Molecular Weight | 244.247 | nRot | 7 |
| Heavy Atom Molecular Weight | 228.119 | nRig | 4 |
| Exact Molecular Weight | 244.106 | nRing | 0 |
| Solubility: LogS | -1.021 | nHRing | 0 |
| Solubility: LogP | -2.776 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 33.5787 |
| nHD | 5 | BPOL | 17.7873 |
| QED | 0.36 |
| Synth | 3.74 |
| Natural Product Likeliness | 0.681 |
| NR-PPAR-gamma | 0.048 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.106 |
| HIA | 0.043 |
| CACO-2 | -6.088 |
| MDCK | 0.00190532 |
| BBB | 0.328 |
| PPB | 0.340707 |
| VDSS | 0.395 |
| FU | 0.697495 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.027 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0.036 |
| CYP2c9-sub | 0.113 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.145 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.031 |
| CL | 8.027 |
| T12 | 0.823 |
| hERG | 0.022 |
| Ames | 0.052 |
| ROA | 0.026 |
| SkinSen | 0.709 |
| Carcinogencity | 0.015 |
| EI | 0.076 |
| Respiratory | 0.458 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.847094 |